Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/10/2002WO2001073017A3 Regulation of human adp-ribosylation factor-related protein
10/10/2002WO2001064869A3 Tumor-related antigen
10/10/2002WO2001053324A8 Novel haptotactic peptides
10/10/2002WO2000047102A3 COMPOSITIONS AND METHODS FOR MODULATING TGF-β SIGNALING
10/10/2002US20020147999 Reducing neuronal tangles in alzhemier's patients; obtain human, administer modulator, monitor development of neuronal tangles in, reduction in neuronal tangles indicates modulator
10/10/2002US20020147997 Animal model for use in the diagnosis, prevention and treatment of cancer
10/10/2002US20020147345 FSH mimetics for the treatment of infertility
10/10/2002US20020147329 Method of modulating tissue growth using Frzb protein
10/10/2002US20020147327 Glucocorticoid receptor protein for use in the treatment of arthritis and asthma
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147323 Nucleotide sequences coding polypeptide for use in the treatment of bone, tumor, psychological and nervous system disorders
10/10/2002US20020147322 Nucleotide sequences coding polypeptides for use in the prevention, diagnosis and treatment of cancer
10/10/2002US20020147320 Novel human kinase proteins and polynucleotides encoding the same
10/10/2002US20020147309 Human N-type calcium channel isoform and uses thereof
10/10/2002US20020147307 Therapeutic and diagnostic agents comprising a socs box
10/10/2002US20020147306 Peptides that modulate the interaction of B class ephrins and PDZ domains
10/10/2002US20020147304 Non-naturally occurring lipoprotein particle
10/10/2002US20020147303 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
10/10/2002US20020147302 Liquid phase peptide synthesis of KL-4 pulmonary surfactant
10/10/2002US20020147301 Parevins and tachytegrins
10/10/2002US20020147203 Tyrosine kinase inhibitors
10/10/2002US20020147172 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
10/10/2002US20020147171 Viability of organs transplants
10/10/2002US20020147170 Constitutively active, hypersensitive, and nonfunctional recepors as novel therapeutic agents
10/10/2002US20020147166 Antisense modulation of Talin expression
10/10/2002US20020147165 Antisense modulation of calreticulin expression
10/10/2002US20020147164 Antisense modulation of cytohesin-1 expression
10/10/2002US20020147163 Antisense modulation of casein kinase 2-alpha expression
10/10/2002US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/10/2002US20020147154 Cosmetic, drugs; extraction, precipitation, washing
10/10/2002US20020147151 IL-16 antagonists
10/10/2002US20020147150 Sustained-release preparation
10/10/2002US20020147146 Antidiabetic agents; Alzheimer's disease
10/10/2002US20020147145 Anticancer, antiproliferative agents
10/10/2002US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002US20020147142 Methods and reducing or maintaining reduced levels of blood lipids using OB protein compositions
10/10/2002US20020147141 Administering caveolin-1 protein
10/10/2002US20020147140 Nucleic acids, proteins, and antibodies
10/10/2002US20020147139 Viricides
10/10/2002US20020147138 Anticancer agents
10/10/2002US20020147137 Medical use of alpha1-acid glycoprotein (AAG) or orosomucoid
10/10/2002US20020147136 Tetrapeptide
10/10/2002US20020147134 Method of preventing and treating the complications of insulin dependent diabetes mellitus
10/10/2002US20020147133 Bifunctional molecules and therapies based thereon
10/10/2002US20020147132 Meltrins
10/10/2002US20020147131 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissue
10/10/2002US20020147129 Polypeptides; nervous system, brain disorders
10/10/2002US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002US20020146823 Propagating mesenchymal stem cells; obtain cells, incubate in preferentially generated propagation mixture, recover cells
10/10/2002US20020146819 Human TSLP DNA and polypeptides
10/10/2002US20020146807 Polypeptides for use in the treatment of cancer; for use as wound healing agent
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146804 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders
10/10/2002US20020146802 Methods for producing and purifying recombinant alpha-L-iduronidase
10/10/2002US20020146801 RNA polymerase I transcription factor TIF-IA
10/10/2002US20020146800 48921, a novel human GTP releasing factor and uses therefor
10/10/2002US20020146799 Enzymes having esterase activity and methods of use thereof
10/10/2002US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002US20020146795 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
10/10/2002US20020146794 Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells
10/10/2002US20020146792 Nucleotide sequences coding protein for use in the treatment of atherosclerosis
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146788 Synthetic peptide for use in the treatment of cancer, inflammation and infections
10/10/2002US20020146775 Novel semaphorin genes (I)
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002US20020146771 Process for producing erythropoietin containing no animal proteins
10/10/2002US20020146770 RAS proteins
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146767 Human EMR1-like G protein-coupled receptor
10/10/2002US20020146761 Detecting gram-negative bacterial infection in human; btain human, inject with labeled endotoxin neutralizing protein, detect label
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146758 Polypeptide for use in the treatment of infections, stroke, reperfusion injuries, nervous system, blood, vision, brain and bone disorders
10/10/2002US20020146757 Nucleotide sequences coding polypeptide for use in the treatment of, muscle, blood, nervous system, gastrointestinal and vision defects
10/10/2002US20020146751 fabF
10/10/2002US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002US20020146749 Diagnosis and treatment of neuroectodermal tumors
10/10/2002US20020146727 Compositions and methods for the therapy and diagnosis of breast cancer
10/10/2002US20020146718 Peptide nucleic acids for use in the treatment and prevention of viral diseases, arthritis, infection, skin, cardiovascular, gastrointestinal and kidney disorders
10/10/2002US20020146711 MMSC2 - an MMAC1 interacting protein
10/10/2002US20020146709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/10/2002US20020146708 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer
10/10/2002US20020146707 Cardiotrophin-1 compositions and methods for the treatment of tumor
10/10/2002US20020146702 Nucleic acid molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
10/10/2002US20020146687 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding
10/10/2002US20020146684 Generating preferential compounds; obtain protection compounds, incubate with chemical intermediates, remove terminal buliding blocks, recover compound
10/10/2002US20020146463 Useful as food additives or in medicaments
10/10/2002US20020146458 Scleral plug containing drug of protein derivatives
10/10/2002US20020146451 Method for the administration of acid-labile drugs
10/10/2002US20020146449 Compositions and methods for the targeted delivery of agents to treat liver cancer
10/10/2002US20020146432 Porcine circoviruses, vaccines and diagnostic reagents
10/10/2002US20020146426 Administering molecule joined to a heat shock protein or molecule joined to an adenosinetriphosphate (ATP) binding domain of a heat shock protein inducing an immune response that includes a CD8+ cytotoxic T lymphocyte (CTL) response
10/10/2002US20020146423 Protective helicobacter antigens
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146420 Protein tyrosine kinase agonist antibodies
10/10/2002US20020146419 Methods of treating ankylosis with chimeric anti-TNF antibodies
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
1 ... 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 ... 3163